Lines of investment

BEIJING Double-Crane Pharmaceutical Co, China's biggest maker of intravenous solutions, said yesterday its will invest more than 90 million yuan (US$13.4 million) to expand its production lines of intravenous solutions in the Anhui and Hubei provinces.